A special HPV vaccination program to prevent cervical cancer has been started since October 24.This campaign will be conducted in all divisions of Bangladesh except for Dhaka. Approximately 6.2 million adolescent girls will receive the vaccine. The vaccines will be offered free of charge to girls who are studying in grades V to IX and are between the ages of 10 and 14 years old.Under the Department of Health, the Expanded Program on Immunization (EPI) of the Directorate General of Health Service... Learn More

On Monday, September 9, 2024, Kate, Princess of Wales, announced the completion of her preventative chemotherapy for cancer. In a heartfelt message accompanying a family video, the 42-year-old royal shared that the experience has given her a renewed perspective and deep gratitude for love. Following major abdominal surgery in January that revealed cancer, Kate has been undergoing treatment. She expressed her intention to participate in a few public engagements later this year but acknowledg... Learn More

Guardian Life Insurance Limited has launched the country's first digital insurance plan for cancer patients. ‘Guardian Cancer Care’ is a low-cost, budget-friendly solution for cancer patients in Bangladesh.Sheikh Rakibul Karim, the company’s CEO, launched this insurance policy on November 14, 2022, at the National Press Club, Dhaka.Guardian Cancer Care is a timely initiative by Guardian Life to financially secure individuals and their families as cancer rates and costs rise wor... Learn More

The 19th SFO International Cancer Conference is scheduled for December 13–14 at the Radisson Blu Dhaka Water Garden, organized by the oncology club. Dr. Mohammad Abdul Hai, the director of the Bangladesh Cancer Hospital and Welfare Home, cordially welcomes health practitioners in oncology sector to participate in this conference. Leading oncologists, including Dr. Mostafa Aziz Sumon (General Secretary of the SAARC Federation of Oncologists), Prof. Dr. A. M. M. Shariful Alam (President of... Learn More

A clinical trial of the world's first mRNA lung cancer vaccine has been started in the UK. Experts stated it as a revolutionary advancement in the treatment of lung cancer.A 67-year-old UK resident has become the first person to take this vaccine.The phase 1 clinical trial has commenced at 34 research sites across seven countries: the UK, the US, Germany, Hungary, Poland, Spain, and Turkey.Additionally, University College London Hospitals NHS Foundation Trust in the UK will conduct a trial with... Learn More